+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dengue Fever Drug"

Dengue Fever - Pipeline Insight, 2021 - Product Thumbnail Image

Dengue Fever - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Dengue - Pipeline Insight, 2020 - Product Thumbnail Image

Dengue - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
From
Dengue Fever - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Dengue Fever - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • August 2021
  • 144 Pages
  • Global
From
Dengue Fever - Pipeline Review, H1 2020 - Product Thumbnail Image

Dengue Fever - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 179 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

The Dengue Fever Drug market is a subset of the larger Infectious Diseases Drugs market. Dengue Fever is a mosquito-borne viral infection that is endemic in tropical and subtropical regions. It is a leading cause of illness and death in many countries. Treatment for Dengue Fever is largely supportive, but there are a few drugs that have been developed to treat the disease. These drugs are typically administered orally or intravenously and are used to reduce the severity of symptoms and shorten the duration of the illness. The market for Dengue Fever Drugs is relatively small, but it is growing as the disease continues to spread. There are a number of companies that are developing and marketing drugs for the treatment of Dengue Fever, including Sanofi, Takeda, and GlaxoSmithKline. Other companies, such as Merck, are also researching potential treatments for the disease. Show Less Read more